Synergy Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of gastrointestinal therapies... Read more
Synergy Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of gastrointestinal therapies... Read more
News
Aug 28, 2023
Bloomberg Law
Synergy Pharmaceuticals Inc.: Synergy Pharma Investors Win Revival of Suit Over Stock Dilution
Oct 14, 2021
Global Legal Chronicle
Synergy Pharmaceuticals Inc.: Synergy Pharmaceuticals' Securities Litigation
Aug 17, 2021
MarketersMedia
Press Release: Synergy Pharmaceuticals Inc. : Synergy Pharmaceutical's relaunch is set to revolutionize conventional medicine's approach to the Herpes Simplex Virus.
Feb 11, 2020
Business News Asia
Synergy Pharmaceuticals: Novel approach from Synergy Pharmaceuticals may hold cure to herpes virus
Feb 10, 2020
BioPortfolio
Synergy Pharmaceuticals: Synergy Pharmaceuticals Inc Strategic SWOT Analysis Review Published by Global Data Prices from USD $106
Apr 30, 2019
4-traders
Synergy Pharmaceuticals: Immuron CEO Dr. Gary S. Jacob to Present at the ThinkEquity Conference on May 2, 2019
Apr 11, 2019
4-traders
Synergy Pharmaceuticals: FRIDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Synergy Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Apr 02, 2019
Market Exclusive
Synergy Pharmaceuticals: SYNERGY PHARMACEUTICALS INC. (NASDAQ:SGYP) Files An 8-K Bankruptcy or Receivership
Mar 28, 2019
4-traders
Synergy Pharmaceuticals: SHAREHOLDER ALERT:� Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -�SGYP
Mar 22, 2019
4-traders
Synergy Pharmaceuticals: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -�SGYP
Synergy Pharmaceuticals Inc. Competitors
1
2
3
4
5
6
7
8
9
10